(Q30383579)

English

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

multicenter clinical trial

0 references

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Zoltan Vajo

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Ferenc Tamas

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Laszlo Sinka

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Istvan Jankovics

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

15 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

375

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

9708

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

49-55

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Inactivated whole virus influenza A (H5N1) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and direct

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza A (H5N1) pandemic prototype vaccine Fluval.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Annual revaccination against influenza and mortality risk in community-dwelling elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Flu-vaccine makers toil to boost supply

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962039-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)62039-0

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30383579&oldid=1549951065"